MedPath

Effect of combined magnesium and vitamin E supplementation in treatment of women with gestational diabetes mellitus

Phase 3
Conditions
Gestational diabetes mellitus.
Unspecified diabetes mellitus in pregnancy, childbirth and the puerperium
O24.9
Registration Number
IRCT20170513033941N24
Lead Sponsor
Arak University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
60
Inclusion Criteria

Patients with gestational diabetes
aged 18 to 40 years

Exclusion Criteria

Taking magnesium and vitamin E supplements 3 months before the intervention
Insulin therapy required during the intervention
Pre-eclampsia
Eclampsia
Hypo and hyperthyroidism
Smokers

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Insulin. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Elisa kit.;Insulin resistance. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Calculation using HOMA formula.
Secondary Outcome Measures
NameTimeMethod
Total cholesterol. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;Triglycerides. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;HDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;LDL. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.;FPG. Timepoint: At the beginning of the study and after 6 weeks of intervention. Method of measurement: Enzymatic kit.
© Copyright 2025. All Rights Reserved by MedPath